These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34944730)

  • 1. Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem.
    Le Garf S; Nègre V; Anty R; Gual P
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD).
    Roeb E
    Visc Med; 2021 Aug; 37(4):273-280. PubMed ID: 34540943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and nonalcoholic fatty liver disease.
    Kountouras J; Kazakos E; Kyrailidi F; Polyzos SA; Zavos C; Arapoglou S; Boziki M; Mouratidou MC; Tzitiridou-Chatzopoulou M; Chatzopoulos D; Doulberis M; Papaefthymiou A; Vardaka E
    Ann Gastroenterol; 2023; 36(3):244-256. PubMed ID: 37144011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies.
    Habibullah M; Jemmieh K; Ouda A; Haider MZ; Malki MI; Elzouki AN
    Front Med (Lausanne); 2024; 11():1291501. PubMed ID: 38323033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
    Flisiak-Jackiewicz M; Bobrus-Chociej A; Wasilewska N; Lebensztejn DM
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33804296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.
    Lin H; Zhang X; Li G; Wong GL; Wong VW
    J Clin Transl Hepatol; 2021 Dec; 9(6):972-982. PubMed ID: 34966660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
    Kjær MB; George J; Kazankov K; Grønbæk H
    Expert Rev Gastroenterol Hepatol; 2021 Jan; 15(1):51-64. PubMed ID: 32878486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health.
    Ramírez-Mejía MM; Díaz-Orozco LE; Barranco-Fragoso B; Méndez-Sánchez N
    Med Sci Monit; 2021 Aug; 27():e934134. PubMed ID: 34456329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic.
    Mărginean CO; Meliț LE; Săsăran MO
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children.
    Rupasinghe K; Hind J; Hegarty R
    J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):583-591. PubMed ID: 37592398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.
    Kulkarni AV; Sarin SK
    Ther Adv Endocrinol Metab; 2023; 14():20420188231178370. PubMed ID: 37323163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease.
    Kaya E; Yilmaz Y
    Ther Adv Endocrinol Metab; 2022; 13():20420188221139650. PubMed ID: 36533185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches.
    Dongiovanni P; Paolini E; Corsini A; Sirtori CR; Ruscica M
    Eur J Clin Invest; 2021 Jul; 51(7):e13519. PubMed ID: 33583033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects.
    Ampuero J; Aller R; Gallego-Durán R; Crespo J; Abad J; González-Rodríguez Á; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Martín-Mateos R; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Hernández-Guerra M; Augustín S; Pareja-Megia MJ; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero-Gómez M;
    Liver Int; 2021 Sep; 41(9):2076-2086. PubMed ID: 33896100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis.
    Segura-Azuara NLÁ; Varela-Chinchilla CD; Trinidad-Calderón PA
    Front Med (Lausanne); 2021; 8():774079. PubMed ID: 35096868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study.
    Baratta F; Ferro D; Pastori D; Colantoni A; Cocomello N; Coronati M; Angelico F; Del Ben M
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases.
    Gutiérrez-Cuevas J; Santos A; Armendariz-Borunda J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Khan FZ; Perumpail RB; Wong RJ; Ahmed A
    World J Hepatol; 2015 Aug; 7(18):2155-61. PubMed ID: 26328027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.